Under the agreement, Amedica will assist Spinal Kinetics with proprietary design, development, manufacture and supply of silicon nitride spinal implants. Silicon nitride is a biomaterial that can be shaped and engineered into complex designs and surfaces to address a variety of medical needs.
“This agreement further expands our use of Amedica’s silicon nitride technology platform and will now allow us to take this biomaterials directly to our customers and develop it according to their specifications,” said Spinal Kinetics CEO Tom Afzal.
More articles on orthopedic devices:
NASS 2014: 17 key device updates & showings
Novabone Products releases bioactive strip for bone growth
Spinal Elements celebrates 2-year launch of Hero Allograft
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
